Welcome to our dedicated page for Quantum X Labs SEC filings (Ticker: QXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Quantum X Labs's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Quantum X Labs's regulatory disclosures and financial reporting.
Quantum X Labs Inc. reported unaudited results for the quarter ended March 31, 2026, showing a small business focused on quantum technology and digital advertising that is still losing money. Revenue from continuing operations was $353 thousand, down from $529 thousand a year earlier, while net loss attributable to shareholders narrowed to $605 thousand from $3.7 million. Total assets rose to $27.7 million, mainly because of the March 4, 2026 acquisition of Quantum X Labs Ltd. in Israel, which added $14.3 million of goodwill and $1.2 million of in-process R&D.
Cash and cash equivalents were $1.8 million as of March 31, 2026, against bank loans of about $1.4 million and an accumulated deficit of $46.7 million. Management explicitly states that declining revenues, continued losses and reliance on external financing raise substantial doubt about the company’s ability to continue as a going concern, even after raising $1.4 million in a March 2026 private placement and completing its Nasdaq uplisting and earlier 2025 financings.
Quantum X Labs Inc. is providing audited 2025 financials and pro forma data for its March 4, 2026 acquisition of Quantum X Labs Ltd. in Israel. The acquired business generated no revenue in 2025, recorded a $325 thousand net loss and faces a going concern uncertainty due to ongoing losses and financing needs. Pro forma 2025 results combine $1.57 million of revenue with a $21.14 million net loss. The acquisition reflects a total purchase cost of $15.89 million, including a $10.67 million share and warrant consideration and a $5.22 million earn-out, creating $20.72 million of goodwill and $3.65 million of intangible assets on the combined balance sheet.